A simple blood test identified women at higher risk for dementia up to 25 years before symptoms appeared. Higher levels of the biomarker p-tau217 were linked to a much greater chance of developing ...
Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.